208 related articles for article (PubMed ID: 29377264)
1. Understanding fibrosis in eosinophilic esophagitis: Are we there yet?
Armbruster-Lee J; Cavender CP; Lieberman JA; Samarasinghe AE
J Leukoc Biol; 2018 Jul; 104(1):31-40. PubMed ID: 29377264
[TBL] [Abstract][Full Text] [Related]
2. Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids.
Rajan J; Newbury RO; Anilkumar A; Dohil R; Broide DH; Aceves SS
J Allergy Clin Immunol; 2016 Jan; 137(1):147-156.e8. PubMed ID: 26233926
[TBL] [Abstract][Full Text] [Related]
3. Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.
Kagalwalla AF; Akhtar N; Woodruff SA; Rea BA; Masterson JC; Mukkada V; Parashette KR; Du J; Fillon S; Protheroe CA; Lee JJ; Amsden K; Melin-Aldana H; Capocelli KE; Furuta GT; Ackerman SJ
J Allergy Clin Immunol; 2012 May; 129(5):1387-1396.e7. PubMed ID: 22465212
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilic Esophagitis: Relationship of Subepithelial Eosinophilic Inflammation With Epithelial Histology, Endoscopy, Blood Eosinophils, and Symptoms.
Schoepfer AM; Simko A; Bussmann C; Safroneeva E; Zwahlen M; Greuter T; Biedermann L; Vavricka S; Godat S; Reinhard A; Saner C; Maye H; Sempoux C; Brunel C; Blanchard C; Simon D; Simon HU; Straumann A
Am J Gastroenterol; 2018 Mar; 113(3):348-357. PubMed ID: 29336433
[TBL] [Abstract][Full Text] [Related]
5. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.
Munoz-Persy M; Lucendo AJ
Eur J Pediatr; 2018 May; 177(5):649-663. PubMed ID: 29549437
[TBL] [Abstract][Full Text] [Related]
6. Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: a historical cohort.
Lieberman JA; Morotti RA; Konstantinou GN; Yershov O; Chehade M
Allergy; 2012 Oct; 67(10):1299-307. PubMed ID: 22913672
[TBL] [Abstract][Full Text] [Related]
7. Eosinophilic esophagitis: current perspectives from diagnosis to management.
Moawad FJ; Cheng E; Schoepfer A; Al-Haddad S; Bellizzi AM; Dawson H; El-Zimaity H; Guindi M; Penagini R; Safrooneva E; Chehade M
Ann N Y Acad Sci; 2016 Sep; 1380(1):204-217. PubMed ID: 27467185
[TBL] [Abstract][Full Text] [Related]
8. Tissue remodeling in eosinophilic esophagitis.
Cheng E; Souza RF; Spechler SJ
Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(11):G1175-87. PubMed ID: 23019192
[TBL] [Abstract][Full Text] [Related]
9. Obtaining adequate lamina propria for subepithelial fibrosis evaluation in pediatric eosinophilic esophagitis.
Wang J; Park JY; Huang R; Souza RF; Spechler SJ; Cheng E
Gastrointest Endosc; 2018 May; 87(5):1207-1214.e3. PubMed ID: 29309779
[TBL] [Abstract][Full Text] [Related]
10. Esophageal remodeling in eosinophilic esophagitis.
Shaker A
Curr Opin Gastroenterol; 2024 Jul; 40(4):291-298. PubMed ID: 38661722
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-stromal crosstalk and fibrosis in eosinophilic esophagitis.
Muir AB; Wang JX; Nakagawa H
J Gastroenterol; 2019 Jan; 54(1):10-18. PubMed ID: 30101408
[TBL] [Abstract][Full Text] [Related]
12. Antifibrotic Effects of the Thiazolidinediones in Eosinophilic Esophagitis Pathologic Remodeling: A Preclinical Evaluation.
Nhu QM; Hsieh L; Dohil L; Dohil R; Newbury RO; Kurten R; Moawad FJ; Aceves SS
Clin Transl Gastroenterol; 2020 Apr; 11(4):e00164. PubMed ID: 32352681
[TBL] [Abstract][Full Text] [Related]
13. TGF-β1-induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis.
Rawson R; Yang T; Newbury RO; Aquino M; Doshi A; Bell B; Broide DH; Dohil R; Kurten R; Aceves SS
J Allergy Clin Immunol; 2016 Sep; 138(3):791-800.e4. PubMed ID: 27212082
[TBL] [Abstract][Full Text] [Related]
14. Remodeling and fibrosis in chronic eosinophil inflammation.
Aceves SS
Dig Dis; 2014; 32(1-2):15-21. PubMed ID: 24603375
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis.
Hirano I; Aceves SS
Gastroenterol Clin North Am; 2014 Jun; 43(2):297-316. PubMed ID: 24813517
[TBL] [Abstract][Full Text] [Related]
16. Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk.
Shoda T; Wen T; Caldwell JM; Ben-Baruch Morgenstern N; Osswald GA; Rochman M; Mack LE; Felton JM; Abonia JP; Arva NC; Atkins D; Bonis PA; Capocelli KE; Collins MH; Dellon ES; Falk GW; Gonsalves N; Gupta SK; Hirano I; Leung J; Menard-Katcher PA; Mukkada VA; Putnam PE; Rudman Spergel AK; Spergel JM; Wechsler JB; Yang GY; Aceves SS; Furuta GT; Rothenberg ME;
Gastroenterology; 2022 Feb; 162(2):439-453. PubMed ID: 34687736
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-Fibroblast Crosstalk in Eosinophilic Esophagitis.
Muir AB; Karakasheva TA; Whelan KA
Cell Mol Gastroenterol Hepatol; 2024; 17(5):713-718. PubMed ID: 38316214
[TBL] [Abstract][Full Text] [Related]
18. Eosinophilic Esophagitis: Pathophysiology and Definition.
Clayton F; Peterson K
Gastrointest Endosc Clin N Am; 2018 Jan; 28(1):1-14. PubMed ID: 29129294
[TBL] [Abstract][Full Text] [Related]
19. Smad3-deficient mice have reduced esophageal fibrosis and angiogenesis in a model of egg-induced eosinophilic esophagitis.
Cho JY; Doshi A; Rosenthal P; Beppu A; Miller M; Aceves S; Broide D
J Pediatr Gastroenterol Nutr; 2014 Jul; 59(1):10-6. PubMed ID: 24590208
[TBL] [Abstract][Full Text] [Related]
20. Monitoring and modulating the trajectory of eosinophilic esophagitis.
Pomenti SF; Bailey DD; Katzka DA
J Allergy Clin Immunol; 2024 Jun; 153(6):1465-1471. PubMed ID: 38570041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
